On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair ... with the scientific team ...

So far this year, Eli Lilly (NYSE ... just yet if I were in Lilly's position. Ever feel like you missed the boat in buying ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

"Mural launched as a stand-alone company one year ago with a mission to shepherd in the second ... strategy and played a key ...

ETFs give investors exposure to numerous publicly traded companies under a single ticker symbol. Some of them follow ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight ... If you’re tired of feeling one step ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Polen Global Growth Fund initiated a new position in Oracle and did not eliminate any positions. Volatility re-emerged in the ...

Some 31 teams took part, but there could only be one winner. After a hard-fought clash over seven rounds of financial trivia, ...